A. Turrisi

发表

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

V. Rusch, R. Livingston, D. Gandara, 2009, The Lancet.

National Institutes of Health State-of-the-Science Conference Statement

J. Unützer, B. Levin, A. Turrisi, 2005, Journal of palliative medicine.

Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.

Randall K Ten Haken, Avraham Eisbruch, Theodore S Lawrence, 2006, International journal of radiation oncology, biology, physics.

Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis.

R K Ten Haken, B A Fraass, M K Martel, 1994, International journal of radiation oncology, biology, physics.

Prophylactic cranial irradiation in small-cell lung cancer: is it still controversial or is it a no-brainer?

A. Turrisi, 2000, The oncologist.

National Institutes of Health State-of-the-Science Conference Statement: Symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002.

J. Unützer, D. Patrick, B. Levin, 2004, Journal of the National Cancer Institute. Monographs.

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

J. Crowley, G. Giaccone, A. Nicholson, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients.

R K Ten Haken, B A Fraass, M K Martel, 1999, Lung cancer.

Docetaxel-based combined-modality chemoradiotherapy for locally advanced non-small cell lung cancer.

G. Scagliotti, A. Turrisi, 2003, The oncologist.

Gemzar (Gemcitabine) with thoracic radiotherapy- A phase II pilot study in chemonaive patients with advanced non-small cell lung cancer (NSCLC) [abstract]

P. Scalliet, A. Turrisi, H. Groen, 1998 .

Locally advanced esophageal cancer

M. Wallace, C. Reed, A. Turrisi, 2002, Current treatment options in oncology.

National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002.

J. Unützer, B. Levin, A. Turrisi, 2004 .

Toxicity of WR-2721 administered in single and multiple doses.

J. Glick, A. Turrisi, L. Coia, 1984, International journal of radiation oncology, biology, physics.

Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors

Charles R. Thomas, P. Rust, J. Nuyttens, 2000, Cancer.

The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer.

W. Curran, H. Sandler, A. Turrisi, 1990, International journal of radiation oncology, biology, physics.

The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification

Fergus Gleeson, Heber MacMahon, Jin Mo Goo, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Lunx Is a Superior Molecular Marker for Detection of Non-Small Lung Cell Cancer in Peripheral Blood

G. Silvestri, C. Reed, A. Turrisi, 2003 .

Evidence for management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

A. Turrisi, G. Simon, N. Aronson, 2007, Chest.

Small cell lung cancer: state of the art and future perspectives.

R. Stupp, S. Leyvraz, A. Turrisi, 2004, Lung cancer.

Platinum combined with radiation therapy in small cell lung cancer: focusing like a laser beam on crucial issues.

A. Turrisi, 1994, Seminars in oncology.

Phase II Study of Pemetrexed and Cisplatin, with Chest Radiotherapy Followed by Docetaxel in Patients with Stage III Non-small Cell Lung Cancer

A. Wozniak, A. Turrisi, S. Gadgeel, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

ACCP Evidence-Based Clinical Practice : * Management of Small Cell Lung Cancer

A. Turrisi, G. Simon, 2007 .

Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

A. Turrisi, G. Simon, George R Simon, 2007, Chest.

A preliminary report: concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer.

A. Turrisi, B. Mason, D. Glover, 1988, International journal of radiation oncology, biology, physics.

Limited stage small cell lung cancer: Treatment and therapy

A. Turrisi, 2003, Current treatment options in oncology.

The treatment of limited small cell lung cancer: a report of the progress made and future prospects.

A. Turrisi, C. Sherman, 2002, European journal of cancer.

Report from the Radiation Oncology Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2003

Charles R. Thomas, P. Okunieff, B. Teicher, 2003, American journal of clinical oncology.

Volume and dose parameters for survival of non-small cell lung cancer patients.

M. Martel, M. Strawderman, M. Strawderman, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Brain irradiation and systemic chemotherapy for small-cell lung cancer: dangerous liaisons?

A. Turrisi, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Since chemotherapy is now the standard in node-positive lung cancer, what is the role of postoperative radiotherapy?

A. Turrisi, S. Keller, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The sound and fury about postoperative therapy for lung cancer.

A. Turrisi, 1992, Mayo Clinic proceedings.

Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group.

D. Osoba, R. Livingston, D. Gandara, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

Thomas J. Smith, Thomas J Smith, William Sause, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: a preliminary report of a phase I dose escalation trial from the Carolina Conformal Therapy Consortium.

M. Socinski, S. Zhou, M. Anscher, 2001, The oncologist.

Pediatric midbrain tumors: a benign subgroup of brainstem gliomas.

J. Brunberg, P. Robertson, K. Muraszko, 1995, Pediatric neurosurgery.

Phase I/II trials of WR-2721 and cis-platinum.

J. Glick, K. Fox, A. Turrisi, 1986, International journal of radiation oncology, biology, physics.

Thorascopic wedge resection and radiotherapy for T1N0 non-small cell lung cancer (NSCLC) in high risk patients: Preliminary analysis of a cancer and leukemia group B and Eastern Cooperative Oncology Group phase II trial

Michael R. Green, D. Sugarbaker, J. Herndon, 2000 .

Lung Toxicity in the Treatment of Lung Cancer: Thoughts at the End of the Millennium

Charles R. Thomas, A. Turrisi, T. Williams, 1999 .

The nonsurgical management of lung cancer: a 1989 perspective for small cell and the non-small cell histologies.

A. Turrisi, 1990, Seminars in roentgenology.

Small cell lung cancer.

A. Gregor, P. Rocmans, P. Postmus, 1997, Lung cancer.

Final report on phase I trial of WR-2721 before protracted fractionated radiation therapy.

P. Rubin, A. Turrisi, M. Kligerman, 1988, International journal of radiation oncology, biology, physics.

Pharmacokinetics of WR-2721.

L. Shaw, J. Glick, A. Turrisi, 1988, Pharmacology & therapeutics.

Pretreatment minimal staging for non-small cell lung cancers: a consensus report

U. Pastorino, R. Stahel, A. Turrisi, 1991 .

M19-02: Bi-modality versus tri-modality therapy in stage IIIa NSCLC: Where does the data lead us?

A. Turrisi, 2007 .

O-035 Phase III trial of concurrent chemotherapy and radiotherapy(CT/RT) vs CT/RT followed by surgical resection for stage IIIa(pN2)non-small cell lung cancer (NSCLC): Outcomes and implications for surgical management in North American Intergroup 0139 (RTOG 9309)

V. Rusch, R. Livingston, F. Shepherd, 2005 .

The thrill of victory; the agony of defeat.

A. Turrisi, 2008, International journal of radiation oncology, biology, physics.

A case against surgery for most IIIa non-small cell lung cancer.

A. Turrisi, 2005, Seminars in oncology.

Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin-etoposide and daily thoracic radiotherapy in limited small-cell lung cancer.

Charles R. Thomas, J. Crowley, R. Livingston, 2001, Lung cancer.

Radiotherapy for Non-Small Cell Lung Cancer

A. Turrisi, 1991 .

Pulmonary toxicity after radiation and bleomycin: a review.

J. Schwade, A. Turrisi, F. Muggia, 1979, International journal of radiation oncology, biology, physics.

The evolving role of radiation therapy in the treatment of locally advanced lung cancer.

A. Turrisi, M. Hazuka, 1993, Seminars in oncology.

14 A randomized study of CODE plus thoracic irradiation versus alternating CAVEP for extensive stage small cell lung cancer (ESCLC): An intergroup study of the national cancer institute of Canada and the southwest oncology group

R. Livingston, F. Shepherd, D. Walde, 1997 .

Therapeutic Options in Locally Advanced Thymoma

G. Giaccone, A. Turrisi, P. Loehrer, 1997 .

70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808.

J. Herndon, A. Turrisi, Mark R. Green, 2004, International journal of radiation oncology, biology, physics.

Limited small-cell lung cancer: a potentially curable disease.

A. Turrisi, C. Sherman, C. R. Rocha Lima, 2000, Oncology.

Current perspectives in the treatment of small cell lung cancer

A. Turrisi, 1993 .

Innovations in multimodality therapy for lung cancer. Combined modality management of limited small-cell lung cancer.

A. Turrisi, 1993, Chest.

Small-Cell Carcinoma of the Lung

A. Turrisi, 1991 .

Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapy.

J. Glick, K. Fox, A. Turrisi, 1988, Pharmacology & therapeutics.

Human pharmacokinetics of WR-2721.

L. Shaw, A. Turrisi, M. Kligerman, 1986, International journal of radiation oncology, biology, physics.

Southwest Oncology Group: two decades of experience in non-small cell lung cancer.

J. Crowley, D. Gandara, L. Gaspar, 2005, Seminars in oncology.

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.

W. Curran, R. Livingston, W. Sause, 1995, Journal of the National Cancer Institute.

It's about time, or is it volume, fractionation, or technique?

A. Turrisi, 1996, International journal of radiation oncology, biology, physics.

Creeping phase II-ism and the medical pharmaceutical complex: weapons of mass distraction in the war against lung cancer.

A. Turrisi, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Influence of Celiac Axis Lymph Nodes in the Definitive Treatment of Esophageal Cancer

C. Reed, D. Sinha, A. Turrisi, 2003, American journal of clinical oncology.

Commentary (Turrisi): Treatment of Stage I-III Non-Small-Cell Lung Cancer in the Elderly

A. Turrisi, 2006 .

Novel doublets in extensive-stage small-cell lung cancer: a randomized phase II study of topotecan plus cisplatin or paclitaxel (CALGB 9430).

T. Lynch, J. Herndon, A. Turrisi, 2002, Clinical lung cancer.

Limited-disease small-cell lung cancer research: sense and nonsense.

A. Turrisi, 2004, International journal of radiation oncology, biology, physics.

Combined modality therapy for limited small cell lung cancer

A. Turrisi, 1997 .

Combined platinum etoposide with radiation therapy in limited stage small cell lung cancer: an effective treatment strategy.

A. Turrisi, 1995, Lung cancer.

Incorporation of radiotherapy fractionation in the combined-modality treatment of limited small-cell lung cancer.

A. Turrisi, 1993, Chest.

Thoracic radiotherapy variables: influence on local control in small cell lung cancer limited disease.

A. Turrisi, D. Glover, 1990, International journal of radiation oncology, biology, physics.

Thoracic radiation therapy: dosage and techniques

A. Turrisi, 1989 .

Response to Seydel.

A. Turrisi, B. Mason, D. Glover, 1988, International journal of radiation oncology, biology, physics.

The integration of platinum and radiotherapy in the treatment of lung cancer.

A. Turrisi, 1991, Seminars in oncology.

Adjuvant radiotherapy for recurrent granular cell tumor

A. Turrisi, V. Livolsi, S. Rosenthal, 1990, Cancer.

Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.

R. Arriagada, J. Pignon, S. Mandrekar, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose-volume relationship for acute side effects during high dose conformal radiotherapy for prostate cancer.

P. Rust, J. Nuyttens, A. Turrisi, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiation therapy as an alternative to surgery in the management of intracranial juvenile nasopharyngeal angiofibroma.

A. Turrisi, B. Wiatrak, C. Koopmann, 1993, International journal of pediatric otorhinolaryngology.

Radiation and chemotherapy sensitizers and protectors.

C. Coleman, A. Turrisi, 1990, Critical reviews in oncology/hematology.

Palliative radiotherapy for metastatic malignant melanoma: brain metastases, bone metastases, and spinal cord compression.

L. Solin, A. Turrisi, W. Rate, 1988, International journal of radiation oncology, biology, physics.

A Liquid Chromatographic Electrochemical Assay for S-2-(3-Aminopropylamino) Ethylphosphorothioate (WR2721) in Human Plasma

L. Shaw, A. Turrisi, D. Glover, 1984 .

Final report of the phase I trial of single-dose WR-2721 [S-2-(3-aminopropylamino)ethylphosphorothioic acid].

J. Glick, A. Turrisi, S. Hurwitz, 1986, Cancer treatment reports.

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

A. Nicholson, R. Rami-Porta, J. V. van Meerbeeck, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Treatment of Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline.

G. Giaccone, C. Rudin, Nofisat Ismaila, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide.

R. Komaki, R. Livingston, W. Sause, 1999, The New England journal of medicine.

Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019.

J. Crowley, R. Livingston, D. Gandara, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer

J. Crowley, R. Rami-Porta, A. Turrisi, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

J. Crowley, G. Giaccone, N. Girard, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

J. Crowley, G. Giaccone, N. Girard, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309)

Michael R. Green, D. Gandara, F. Shepherd, 2005 .

Results of primary and adjuvant CT-based 3-dimensional radiotherapy for malignant tumors of the paranasal sinuses.

M. Martel, H. Sandler, W. Roa, 1994, International journal of radiation oncology, biology, physics.

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.

J. Crowley, K. Stelzer, V. Rusch, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Induction paclitaxel/carboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited-access study--CALGB 9534.

H. Choy, J. Herndon, E. Vokes, 2005, Clinical lung cancer.

R. Komaki, R. Livingston, W. Sause, 2000 .

R. Livingston, W. Sause, A. Turrisi, 2000, Cancer.

Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection.

W. Curran, A. Turrisi, J. Brooks, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer.

V. Rusch, A. Turrisi, David H. Johnson, 2007, Journal of the National Cancer Institute.

Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial.

R K Ten Haken, M K Martel, J A Hayman, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected].

G. Silvestri, C. Reed, A. Turrisi, 2003, The Journal of molecular diagnostics : JMD.

A Review of First-Line Treatment for Small-cell Lung Cancer

A. Turrisi, N. Murray, Nevin Murray, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer : Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group

W. Curran, P. Kolesar, R. Livingston, 2000 .

Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group.

W. Curran, P. Kolesar, R. Livingston, 2001, Chest.

Pemetrexed and cisplatin with concurrent thoracic radiation therapy (TRT) followed by docetaxel in stage III non-small cell lung cancer (NSCLC) patients (pts)

A. Wozniak, A. Turrisi, S. Gadgeel, 2008 .

Trends in intensity-modulated radiation therapy use for limited-stage small cell lung cancer: A National Cancer Database analysis

A. Turrisi, R. Wegner, P. Renz, 2018, Applied Radiation Oncology.

Considerations on radiotherapy dose intensity for limited small cell lung cancer.

A. Turrisi, 1994, Lung cancer.

The relative merits of altered fractionation in lung cancer with some emphasis in small cell lung cancer

A. Turrisi, 1993 .

National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002.

J. Unützer, B. Levin, L. Ried, 2003, Journal of the National Cancer Institute.

Concurrent chemoradiotherapy for limited small-cell lung cancer.

A. Turrisi, 1997, Oncology.

Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysis.

M. Martel, R. T. Ten Haken, M. Strawderman, 1993, International journal of radiation oncology, biology, physics.

Dose escalation for non-small cell lung cancer using conformal radiation therapy.

M. Martel, L. Quint, I. Francis, 1997, International journal of radiation oncology, biology, physics.

Cost Effectiveness of Modified Fractionation Radiotherapy versus Conventional Radiotherapy for Unresected Non–Small-Cell Lung Cancer Patients

H. Choy, R. Arriagada, J. Pignon, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Caring for the dying patient with lung cancer.

G. Silvestri, A. Turrisi, P. Flume, 2002, Chest.

PL-4 Phase III study of concurrent chemotherapy and full course radiotherapy (CT/RT) versus CT/RT induction followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): First outcome analysis of North American Intergroup trial 0139 (RTOG 93-09)

D. Gandara, K. Albain, A. Turrisi, 2003 .

Cortical versus medullary thymomas: a useful morphologic distinction?

W. Curran, A. Turrisi, J. Brooks, 1988, Human pathology.

Palliative radiotherapy for metastatic malignant melanoma

L. Solin, A. Turrisi, W. Rate, 1987 .

Counterpoint: better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation.

A. Turrisi, C. Thomas, T. E. Williams, 2000, Seminars in radiation oncology.

Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for the treatment of limited small cell lung cancer: a preliminary report.

A. Turrisi, B. Mason, D. Glover, 1988, Antibiotics and chemotherapy.

Postoperative radiotherapy in resected non-small-cell lung cancer: Every creek has two banks

A. Turrisi, David H. Johnson, 2000, Current oncology reports.

Fraction size and dose parameters related to the incidence of pericardial effusions.

R K Ten Haken, M K Martel, M L Kessler, 1998, International journal of radiation oncology, biology, physics.

Once-daily radiotherapy to ≥59.4 Gy versus twice-daily radiotherapy to ≥45.0 Gy with concurrent chemotherapy for limited-stage small-cell lung cancer: a comparative analysis of toxicities and outcomes

A. Turrisi, J. Watkins, K. Shirai, 2010, Japanese Journal of Radiology.

109 RTOG 8808 ECOG 4588, preliminary analysis of a phase III trial in regionally advanced unresectable now small cell lung cancer with minimum three year follow-up

W. Curran, R. Komaki, R. Livingston, 1995 .

Spinal cord dose in limited stage small cell lung cancer: a preliminary quality assurance review committee (QARC) report on CALGB 39808, using target thoracic radiotherapy (TRT) doses of 60 – 70 Gy

J. Herndon, A. Turrisi, Mark R. Green, 2001 .

Principles and practice of lung cancer: The official reference text of the International Association for the Study of Lung Cancer (IASLC): Fourth edition

J. Minna, G. Scagliotti, D. Carbone, 2012 .

Use of Veff and iso-NTCP in the implementation of dose escalation protocols.

R K Ten Haken, M K Martel, M L Kessler, 1993, International journal of radiation oncology, biology, physics.

Conformal High Dose External Radiation Therapy, 80.5 Gy, Alone for Medically Inoperable Non-small Cell Lung Cancer: A Retrospective Analysis

G. Silvestri, A. Turrisi, J. Urbanic, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The use of spiral ct and spirometry to reduce uncertainties in treatment planning associated with breathing

K. Lam, J. Balter, J. Robertson, 1994 .

Dose escalation and associated predictors of survival with consolidative thoracic radiotherapy in extensive stage small cell lung cancer (SCLC): A National Cancer Database (NCDB) propensity-matched analysis.

A. Turrisi, G. Finley, R. Wegner, 2018, Lung cancer.

Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904.

E. Vokes, A. Turrisi, Mark R. Green, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Don't be mis-guided when the data are silent and the editorial misses the mark.

A. Turrisi, C. Thomas, T. E. Williams, 1998, Journal of Clinical Oncology.

Management of CNS metastases in small cell lung cancer: a consensus report

D. Ettinger, H. Earl, P. Postmus, 1989 .

Concurrent twice-daily radiotherapy (XRT) — platinum (DDP) - etoposide (VP-16) for limited small cell lung cancer (SCLC): Update 1987

A. Turrisi, B. Mason, D. Glover, 1987 .

Use of Vneff and iso-ntcp in the design of dose escalation protocols

M. Martel, T. Lawrence, A. Turrisi, 1992 .

Primary large cell neuroendocrine carcinoma of the vagina: Cytomorphology of previously unreported case

A. Turrisi, H. Saleh, B. Jin, 2010, Diagnostic cytopathology.

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.

M. Iannettoni, M. Orringer, M. Strawderman, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose E scalation i n N on-Small-Cell L ung C ancer U sing Three-Dimensiona l C onformal R adiation T herapy: U pdate of a P hase I T rial

M. Martel, J. Hayman, A. Turrisi, 2001 .

Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group.

D. Ettinger, A. Turrisi, D. Johnson, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A preliminary report: concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer.

A. Turrisi, B. Mason, D. Glover, 1988 .

Role of radiotherapy in the treatment of small cell lung carcinoma.

A. Turrisi, T. E. Williams, 1997, Chest Surgery Clinics of North America.

Cost Effectiveness of Modified Fractionation Radiotherapy versus Conventional Radiotherapy for Unresected Non–Small-Cell Lung Cancer Patients

H. Choy, R. Arriagada, J. Pignon, 2013, Journal of Thoracic Oncology.

Analysis of localization errors in the definition of the mantle field using a beam's eye view treatment-planning system.

H. Sandler, A. Eisbruch, A. Turrisi, 1996, International journal of radiation oncology, biology, physics.

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

J. Crowley, G. Giaccone, A. Nicholson, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.

R. Arriagada, J. Pignon, S. Mandrekar, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.